Ibon Garitaonandia

St George's University Of London
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

TransEndocardial Injection of Autologous Expanded CD34+ Stem Cells (ProtheraCytes®) after myocardial infarction: Impact on Patients' Quality of Life.

TransEndocardial Injection of Autologous Expanded CD34+ Stem Cells (ProtheraCytes®) after myocardial infarction: Impact on Patients' Quality of Life.

Journal: Stem cell reviews and reports
Published: January 27, 2026

Development and Validation of Flow Cytometry-Based Method to Quantify CD34/CD45+ Cells as a Release Criterion of Clinical-Grade Products for a Phase III Clinical Trial.

Development and Validation of Flow Cytometry-Based Method to Quantify CD34/CD45+ Cells as a Release Criterion of Clinical-Grade Products for a Phase III Clinical Trial.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: July 11, 2025

Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Results of the EXCELLENT Trial.

Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction: Results of the EXCELLENT Trial.

Journal: JACC. Heart failure
Published: March 31, 2025

Validation of a potency assay for CD34 + cell based therapy.

Validation of a potency assay for CD34 + cell based therapy.

Journal: Scientific reports
Published: February 20, 2025

Nose-to-brain delivery of stem cells in stroke: the role of extracellular vesicles.

Nose-to-brain delivery of stem cells in stroke: the role of extracellular vesicles.

Journal: Stem cells translational medicine
Published: April 11, 2024

Development of a potency assay for CD34+ cell-based therapy.

Development of a potency assay for CD34+ cell-based therapy.

Journal: Scientific reports
Published: June 06, 2023

Probing Multiple Transplant Delivery Routes of CD+34 Stem Cells for Promoting Behavioral and Histological Benefits in Experimental Ischemic Stroke.

Probing Multiple Transplant Delivery Routes of CD+34 Stem Cells for Promoting Behavioral and Histological Benefits in Experimental Ischemic Stroke.

Journal: Stem cells translational medicine
Published: June 05, 2023

Evaluation of expanded peripheral blood derived CD34+ cells for the treatment of moderate knee osteoarthritis.

Evaluation of expanded peripheral blood derived CD34+ cells for the treatment of moderate knee osteoarthritis.

Journal: Frontiers in bioengineering and biotechnology
Published: January 24, 2023

Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study.

Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study.

Journal: Diagnostic microbiology and infectious disease
Published: July 14, 2021

Derivation of Neural Stem Cells from Human Parthenogenetic Stem Cells.

Derivation of Neural Stem Cells from Human Parthenogenetic Stem Cells.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 19, 2019

Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model.

Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model.

Journal: Theranostics
Published: September 11, 2018

Novel Approach to Stem Cell Therapy in Parkinson's Disease.

Novel Approach to Stem Cell Therapy in Parkinson's Disease.

Journal: Stem cells and development
Published: June 09, 2018
Showing 1-12 of 22

Last Updated: 09/26/2026